Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;78:1966–86.

Article  Google Scholar 

Perazzo H, Pacheco AG, Griep RH, Gracindo R, Goulart AC, Fonseca MDJMD. Changing from NAFLD through MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort. J Hepatol. 2024;80(2):e72–4.

Article  PubMed  Google Scholar 

Hong S, Sun L, Hao Y, Li P, Zhou Y, Liang X, et al. From NAFLD to MASLD: when metabolic comorbidity matters. Ann Hepatol. 2024;29(2): 101281.

Article  CAS  PubMed  Google Scholar 

Crudele L, De Matteis C, Novielli F, Petruzzelli S, Di Buduo E, Graziano G, et al. Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients. Intern Emerg Med. 2024. https://doi.org/10.1007/s11739-024-03596-6.

Article  PubMed  Google Scholar 

Bovenga F, Sabbà C, Moschetta A. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer. Cell Metab. 2015;21(4):517–26.

Article  CAS  PubMed  Google Scholar 

Crudele L, Gadaleta RM, Cariello M, Moschetta A. Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine. 2023;97: 104821.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457–69.

Article  CAS  PubMed  Google Scholar 

Chen KL, Madak-Erdogan Z. Estrogens and female liver health. Steroids. 2018;133:38–43.

Article  CAS  PubMed  Google Scholar 

Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801.

Article  PubMed  Google Scholar 

Platek AE, Szymanska A. Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor. Clin Exp Hepatol. 2023;9(3):187–92.

Article  PubMed  PubMed Central  Google Scholar 

Wu J, Tian S, Li H, Xu Z, Li S, Ling CY, et al. Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data. BMC Gastroenterol. 2022;22(1):265.

Article  PubMed  PubMed Central  Google Scholar 

Sanyal AJ, Castera L, Wong VWS. Noninvasive assessment of liver fibrosis in NAFLD. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2023;21(8):2026–39.

CAS  Google Scholar 

Anstee QM, Castera L, Loomba R. Impact of non-invasive biomarkers on hepatology practice: past, present and future. J Hepatol. 2022;76(6):1362–78.

Article  CAS  PubMed  Google Scholar 

Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis—2021 update. J Hepatol. 2021;75(3):659–89.

Article  Google Scholar 

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–9.

Article  PubMed  Google Scholar 

De Matteis C, Crudele L, Battaglia S, Loconte T, Rotondo A, Ferrulli R, et al. Identification of a novel score for adherence to the mediterranean diet that is inversely associated with visceral adiposity and cardiovascular risk: the Chrono Med Diet Score (CMDS). Nutrients. 2023;15(8):1910.

Article  PubMed  PubMed Central  Google Scholar 

Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med J Br Diabet Assoc. 2006;23(5):469–80.

Article  CAS  Google Scholar 

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-33.

Article  Google Scholar 

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.

Article  PubMed  Google Scholar 

Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14(5):635–7.

Article  PubMed  Google Scholar 

Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. ADIS J; 2018. p. 61537 Bytes. https://adisjournals.figshare.com/articles/NAFLD_as_a_Sexual_Dimorphic_Disease_Role_of_Gender_and_Reproductive_Status_in_the_Development_and_Progression_of_Nonalcoholic_Fatty_Liver_Disease_and_Inherent_Cardiovascular_Risk/6406034/1. Accessed 19 Mar 2023.

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.

Article  PubMed  PubMed Central  Google Scholar 

Biciusca T, Stan SI, Balteanu MA, Cioboata R, Ghenea AE, Danoiu S, et al. The role of the Fatty Liver Index (FLI) in the management of non-alcoholic fatty liver disease: a systematic review. Diagnostics. 2023;13(21):3316.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu J, He M, Zhang Y, Li T, Liu Y, Xu Z, et al. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study. Endocr J. 2018;65(3):373–81.

Article  CAS  PubMed  Google Scholar 

Chen LW, Huang PR, Chien CH, Lin CL, Chien RN. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease. J Formos Med Assoc. 2020;119(1):173–81.

Article  CAS  PubMed  Google Scholar 

Wu J, Li H, Xu Z, Ran L, Quan KL. Population-specific cut-off points of fatty liver index for the diagnosis of hepatic steatosis. J Hepatol. 2021;75(3):726–8.

Article  PubMed  Google Scholar 

Lajeunesse-Trempe F, Boit MK, Kaduka LU, De Lucia-Rolfe E, Baass A, Paquette M, et al. Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population. Trop Med Int Health. 2023;28(10):830–8.

Article  PubMed  Google Scholar 

Guo Y, Hu Y, Yang J, Ma R, Zhang X, Guo H, et al. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang. Eur J Med Res. 2023;28(1):555.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nomura T, Ono M, Kobayashi K, Akaiwa Y, Ayaki M, Ogi T, et al. Validation of fatty liver index as a predictor of hepatic steatosis in Asian populations: Impact of alcohol consumption and sex. Hepatol Res. 2023;53(10):968–77.

Article  CAS  PubMed  Google Scholar 

Yang BL, Wu WC, Fang KC, Wang YC, Huo TI, Huang YH, et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS ONE. 2015;10(3): e0120443.

Article  PubMed  PubMed Central  Google Scholar 

Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(10):3023–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fresneda S, Abbate M, Busquets-Cortés C, López-González A, Fuster-Parra P, Bennasar-Veny M, et al. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study. Biol Sex Differ. 2022;13(1):64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai X, Thorand B, Hohenester S, Prehn C, Cecil A, Adamski J, et al. Association of sex hormones and sex hormone-binding globulin with liver fat in men and women: an observational and Mendelian randomization study. Front Endocrinol. 2023;14:1223162.

Article  Google Scholar 

Arafa A, Kokubo Y, Kashima R, Matsumoto C, Teramoto M, Kusano K. Fatty Liver Index and the risk of atrial fibrillation in a general Japanese population—the Suita study. Circ J. 2023;87(12):1836–41.

Article  PubMed  Google Scholar 

Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate). https://www.who.int/data/gho/data/indicators/indicator-details/GHO/raised-fasting-blood-glucose-(--7-0-mmol-l)-(crude-estimate). Accessed 27 Apr 2024.

Ohkuma T, Komorita Y, Peters SAE, Woodward M. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 2019;62(9):1550–60.

Article  PubMed  PubMed Central  Google Scholar 

Hutchison AL, Tavaglione F, Romeo S, Charlton M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J Hepatol. 2023;79(6):1524–41.

Article  CAS  PubMed  Google Scholar 

Sawada K, Chung H, Softic S, Moreno-Fernandez ME, Divanovic S. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2023;35(11):1852–71.

Article  CAS